Delta Life Science

Delta Life Science builds label-free, multiplexed biosensing instruments based on photonic integrated circuits for life-science research. Its technology lets assay developers, academic labs, and pharma scientists detect biomolecule interactions in real time without ELISA-style tagging, while cutting cost of ownership and speeding workflows. The company aims to make high-performance kinetic screening and biomarker assays accessible beyond labs with large capital budgets. Founded as a TNO spin-off, it commercializes patented photonic biosensor technology for drug-candidate screening, antibody selection, and quantitative assays.